title: Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
abstract: Soluble parasite antigens (SPA) from different Babesia species have been shown earlier to induce protective immunity when used as vaccine. However, initial attempts to produce such vaccine against Babesia rossi infection using SPA from B. rossi culture supernatants were not or only partially successful. Here we show that when dogs were vaccinated with a vaccine comprising SPA from B. rossi combined with SPA from Babesia canis protective immunity against experimental challenge infection was induced. Immunity was reflected in reduced clinical signs that resolved spontaneously, and reduction of parasitaemia and SPA in the blood. Not a single infected erythrocyte could be found in blood smears of dogs that had been repeatedly boosted (three vaccinations in total). In contrast, three out of four control dogs required chemotherapeutic treatment to prevent death. The fourth control dog showed a transient parasitaemia that resolved spontaneously. Vaccination did not prevent the development of a transient anaemia. It is concluded that a vaccine containing a mixture of SPA obtained from in vitro culture supernatants of B. rossi and B. canis induces protection in dogs against heterologous challenge infection with B. canis (as shown before) or B. rossi.
authors.affiliation: Parasitology R&D Department, Intervet International B.V., P.O. Box 31, 5830 AA Boxmeer, The Netherlands. theo.schetters@intervet.com
authors.forename: Th P M
authors.initials: TP
authors.lastname: Schetters
authors.forename: T
authors.initials: T
authors.lastname: Strydom
authors.forename: D
authors.initials: D
authors.lastname: Crafford
authors.forename: J A G M
authors.initials: JA
authors.lastname: Kleuskens
authors.forename: J
authors.initials: J
authors.lastname: van de Crommert
authors.forename: A N
authors.initials: AN
authors.lastname: Vermeulen
mesh_terms: D000818:Animals; D000913:Antibodies, Protozoan / Q000096:biosynthesis; D000953:Antigens, Protozoan; D001403:Babesia / Q000276:immunology*; D001404:Babesiosis / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D004283:Dog Diseases / Q000276:immunology* / Q000517:prevention & control; D004285:Dogs; D004912:Erythrocytes / Q000469:parasitology; D005260:Female; D006400:Hematocrit / Q000662:veterinary; D007117:Immunization, Secondary / Q000662:veterinary; D008297:Male; D018512:Parasitemia / Q000662:veterinary; D016052:Protozoan Vaccines / Q000276:immunology*; D013997:Time Factors
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D016052:Protozoan Vaccines